Ascension Economic Development Corporation won a Gold Rank for its Impact of Industry, a project in the category of Multimedia/Video Promotion of the International Economic Development Council. The ...
CHICAGO--(BUSINESS WIRE)--R.R. Donnelley & Sons Company (RRD), a leading global provider of marketing, packaging, print, and supply chain solutions, today announced that RRD GO Creative was recognized ...
Business Facilities is excited to recognize the recipients of the IEDC 2023 Excellence in Economic Development Awards. Your dedication, innovation, and commitment to fostering economic growth and ...
Recognized for Advancing (Z)-Endoxifen, a Precision-Engineered Endocrine Therapy with Potential Across Multiple Breast Cancer and Rare Disease Settings Atossa earned this recognition for its ...
The key to hospital leaders reaching their goals is developing and implementing tactics that align with the hospital’s strategic plan. Each project the hospital implements — each tactic — should tie ...
SEATTLE — Business Development Resources (BDR), a training and business coaching service for home services industry professionals, announced an opportunity for service industry business owners, ...
There are numerous professionals who influence the technological landscape with their innovative and meticulous work. One such accomplished individual is Gaurav Shah, an expert in embedded software ...
Fort McCoy Directorate of Human Resources (DHR) held a Operation Excellence workforce development course in leader and talent management Oct. 4 in building 2113 at Fort McCoy. Approximately 30 Fort ...
Company recognized for advancing ENV‑105, a first‑in‑class resistance‑modulating antibody for metastatic castration‑resistant prostate cancer Kairos earned this recognition for its work advancing ...
SEATTLE, Dec. 17, 2025 /PRNewswire/ -- Atossa Therapeutics, Inc. (Nasdaq: ATOS) ("Atossa" or the "Company"), a clinical-stage biopharmaceutical company developing novel therapies in oncology and other ...
The MarketWatch News Department was not involved in the creation of this content. Recognized for Advancing (Z)-Endoxifen, a Precision-Engineered Endocrine Therapy with Potential Across Multiple Breast ...